Robot-assisted surgery: Corindus files for $46m uplisting

Corindus Vascular Robotics is looking to raise as much as $46 million for its CorPath robot-assisted surgery device for treating coronary artery disease and uplist its shares to the New York Stock Exchange.

Corindus Vascular Robotics

News Well, Initial Public Offering (IPO), Robot-Assisted Surgery

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1JBSKjb